Adaptive Transfer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells (NCT03554889) | Hangzhou Cancer Hospital | 2018-08-01 |
Track Adaptive Transfer automatically
Every clearance here is in the API, with alerts when new ones post.